Astrocytes, the most abundant cell type in the central nervous system, are intimately associated with synapses. They play a pivotal role in neuronal survival and the brain inflammatory response. Some astrocytic functions are mediated by the secretion of polypeptides. Using a proteomic approach, we have identified more than 30 proteins released by cultured astrocytes. These include proteases and protease inhibitors, carrier proteins and antioxidant proteins. Exposing astrocytes to brefeldin A, which selectively blocks secretory vesicle assembly, suppressed the release of some of these proteins. This indicates that astrocytes secrete these proteins by a classical vesicular mechanism and others by an alternative pathway. Astrocytes isolated from different brain regions secreted a similar pattern of proteins. However, the secretion of some of them, including metalloproteinase inhibitors and apolipoprotein E, was region-specific. In addition, proinflammatory treatments modified the profile of astrocytic protein secretion. Finally, more than two thirds of the proteins identified in the astrocyte-conditioned medium were detectable in the mouse cerebrospinal fluid, suggesting that astrocytes contribute to the cerebrospinal fluid protein content. In conclusion, this study provides the first unbiased characterization of the major proteins released by astrocytes, which may play a crucial role in the modulation of neuronal survival and function.
INTRODUCTION
Glial cells represent the largest cell population in the central nervous system (CNS) 1 . They are divided into three categories: astrocytes, the most abundant glial cell type, oligodendrocytes, the central equivalent of Schwann cells, and microglial cells, which share features with immune cells. For decades, astrocytes were essentially considered to be passive elements providing a structural support for neurons and contributing to the blood brain barrier by wrapping processes around CNS microvessels. Several physiological properties related to CNS homeostasis (clearance and metabolism of neurotransmitters, regulation of extracellular pH and K + level) have also been attributed to astrocytes, which thereby contribute to the maintenance of an ideal environment for neuronal cell function (1) .
Many recent studies have established that astrocytes, which are intimately associated with synapses, are active integrators and regulators of neuronal activity and synaptic transmission (2-6). These astrocytic functions are mediated, at least in part, by the release of various substances including amino acids and polypeptides. Indeed, glutamate released from synaptic terminals not only binds to glutamate receptors on the post-synaptic neurons but also activates AMPA receptors on the surrounding astrocytes. This activation induces a rapid increase in intracellular Ca 2+ and a Ca 2 + -dependent release of glutamate from astrocytes that in turn activates post-synaptic glutamate receptors on neighboring neurons, thereby enhancing excitatory synaptic transmission (7, 8) . A similar modulatory effect involving perisynaptic astrocytes has been demonstrated at inhibitory synapses (9) . A new concept of tripartite synapses based on neuronal-astrocytic cooperation for the processing of information has recently emerged from these findings (10) . A recent study has demonstrated that perisynaptic glial cells of a molluscan cholinergic synapse respond to acetylcholine by releasing a nicotinic receptor-like protein into the synaptic cleft. This protein can capture acetylcholine released
High resolution two-dimensional gel electrophoresis
TCA precipitates were washed three times with diethyl ether and resuspended in 350 µl isoelectrofocusing medium containing urea (7 M), thiourea (2 M), CHAPS (4%), ampholines (preblended, pI 3.5-9.5, 8 mg/ml, Amersham Biosciences, Upsalla, Sweeden), dithiothreitol (DTT, 100 mM), tergitol NP7 (0.2%, Sigma) and traces of bromophenol blue (20) . Proteins (30 µg/gel) were first separated according to their isoelectric point along linear immobilized pH-gradient (IPG) strips (pH 3-10, 18 cm long) using the IPGphor apparatus (Amersham Biosciences). Sample loading for the first dimension was performed by passive in-gel reswelling. After the first dimension, the IPG strips were equilibrated for 10 min in a buffer containing urea (6M), Tris-HCl (50 mM, pH 6.8), glycerol (30%), SDS (2%), DTT (10 mg/ml) and bromophenol blue, and then for 15 min in the same buffer containing 15 mg/ml iodoacetamide instead of DTT. For the second dimension, the strips were loaded onto vertical 12.5% SDS polyacrylamide gels, unless otherwise indicated. The gels were silver stained according to the procedure of Shevshenko et al. (21) .
Image acquisition and two-dimensional gel spot pattern analysis
Gels to be compared were always processed and stained in parallel. Gels were scanned using a computer-assisted densitometer. Spot detection, gel alignment and spot quantification were performed using the Image Master 2D Elite software (Amersham Biosciences). Quantification of proteins was expressed as volumes of spots. To correct for variability resulting from silver staining, results were expressed as relative volumes of all spots in each gel. Data are the means of values from four gels originating from experiments performed on different sets of cultured astrocytes.
MALDI-TOF mass spectrometry and protein identification
Proteins of interest were excised and digested in gel using trypsin (sequencing grade, by guest on September 27, 2016 http://www.jbc.org/
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Promega, Charbonnières, France), as previously described (21) . Digest products were completely dehydrated in a vacuum centrifuge and resuspended in 10 µl formic acid (2%), desalted using Zip Tips C18 (Millipore, Bedford, MA), eluted with 10 µl acetonitriletrifluoroacetic acid (TFA), (80-0.1%) and concentrated to 2 µl. Aliquots (0.5 µl) were mixed with the same volume of α-cyano-4-hydroxy-trans-cinnamic acid (Sigma, 10 mg/ml in acetonitrile-TFA, 50-0.1%) and loaded on the target of a BIFLEX III MALDI-TOF mass spectrometer (Bruker-Franzen Analytik, Bremen, Germany). Analysis was performed in reflectron mode with an accelerating voltage of 20 kV and a delayed extraction of 400 ns.
Spectra were analyzed using the XTOF software (Bruker-Franzen Analytik) and auto- http://www.expasy.org/tools/peptident.html, respectively). A mass deviation of 100 ppm was allowed for data base interrogation, but the mass accuracy of our analyses was usually better than 50 ppm. Coverage of the full-length protein exceeding 15% was considered to be sufficient unless there were some obvious conflicts between the experimental molecular weight or isoelectric point, and those of the identified protein. Matching peptides with one missed cleavage were considered as pertinent only when there were two consecutive basic residues or when arginine and lysine residues were followed by a proline or acidic residues inside the peptide amino acid sequence (22, 23) .
Immunoblotting
Proteins, resolved on one-or two-dimensional (1-D or 2-D) gels, were transferred electrophoretically onto nitrocellulose membranes (Hybond-C, Amersham Biosciences).
Membranes were incubated overnight with primary antibodies. Immunoreactivity was detected with an enhanced chemiluminescence method (Renaissance Plus, NEN DuPont, Boston, MA).
Measurement of astrocyte viability
The viability of astrocyte cultures exposed to pro-inflammatory treatments was assessed by the 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT) assay (24) . Cells were incubated with MTT (60 µg/ml, directly added to the serum-free medium) for 45 min at 37°C. The blue formazan derivative was solubilized in dimethyl sulfoxide and optical density was read at 560 nm. Lack of membrane integrity of astrocytes was also estimated by measuring propidium iodide (PI) incorporation (3 µg/ml, 10 min at room temperature). Cells were then fixed with 4% paraformaldehyde in PBS (30 min at 4°C) and nuclei were stained with Hoechst 33258 (1 µg/ml for 10 min at room temperature). They were then washed successively with PBS and distilled water and mounted in Mowiol under coverslips. Nuclear 
RESULTS

Protein release by mouse striatal astrocytes through a brefeldin A-sensitive pathway
For a first insight into the composition of the proteins secreted by astrocytes, the medium conditioned by confluent striatal astrocytes (18 h at 37°C) was concentrated and proteins (30 µg per gel) were resolved by 2-D electrophoresis. Numerous protein spots were detectable on silver-stained 2-D gels (Fig. 1) . To specifically identify proteins that were released from astrocytes through the vesicular pathway, the extracellular protein pattern was compared to that from astrocytes treated during the secretion period with BFA (1 µg/ml). BFA selectively blocks secretory vesicle assembly and, thus, the secretion of proteins through the classical vesicular pathway. Several spots or groups of spots detected in 2-D gels of conditioned media of control cells were absent in gels obtained from BFA-treated cells ( Figs. 1 and 2 ). These spots were undetectable in 2-D gels of whole cell extracts (30 µg per gel, not shown).
Exposing astrocytes to higher BFA concentrations (up to 10 µg/ml) did not decrease the expression of additional proteins in culture supernatants (data not shown). All proteins secreted by astrocytes through a BFA-sensitive mechanism were identified by MALDI-TOF mass spectrometry (see Table 1 ). These proteins include: 1) proteases (complement C3 α and cyclophilin A, an intracellular protein that binds the immunosuppressive agent cyclosporin A and possesses peptidyl-prolyl cis-transisomerase activity (27) , and 4) a set of antioxidant proteins that may be involved in the defense against oxidative stress. These antioxidant proteins include Cu/Zn superoxide dismutase, gluthatione S-transferase class-mu (GST1) and several thiol-dependent antioxidant proteins such as thioredoxin peroxidases 1 and 2 (these proteins have recently been renamed peroxiredoxins 2 and 1, respectively), and antioxidant protein-2 (AOP2). AOP2 also belongs to the thioredoxin peroxidase family, but this protein has only one conserved cystein residue instead of two. AOP2 was therefore called 1-Cys peroxiredoxin (28) . An extracellular location has been proposed for some of these proteins (29, 30) . Finally, several cytosolic proteins including enzymes and brain-enriched 14-3-3
proteins were also found in the medium conditioned by striatal astrocytes. Altogether, these results suggest that astrocytes can secrete substantial amounts of various proteins through a mechanism independent of the classical vesicular pathway.
Regional specificity of astrocytic protein release
To examine the regional specificity of astrocytic protein release, we compared the pattern of proteins in the medium conditioned by striatal astrocytes with the pattern of proteins released by cultures of astrocytes isolated from other CNS regions. A similar profile of extracellular proteins was found in the medium conditioned by astrocytes from the striatum, the cerebral cortex, the hippocampus and the cerebellum, with a few remarkable differences, which are depicted in Fig. 4 . Striatal astrocytes released larger amounts of apolipoprotein E than did astrocytes originating from the other brain regions examined. In contrast, striatal astrocytes secreted the lowest amounts of IBP-2. A regional specificity was also observed for the release of metalloproteinase inhibitors. Indeed, TIM-2 was only detectable in the supernatant of striatal astrocytes, whereas TIM-1 was specifically released by astrocytes from the cerebellum. AOP2, a protein which is released by a BFA-insensitive pathway, was greatly enriched in the conditioned medium of striatal, cortical and hippocampal astrocytes (about 2% of total extracellular protein content), compared with that measured in the supernatant of cerebellar cultures (0.28 ± 0.07 % of total extracellular protein content, n = 4) (Fig 4) .
Effects of pro-inflammatory treatments on astrocytic protein release
It is well documented that astrocytes play a pivotal role in the type and extent of CNS immune and inflammatory response, in part by their ability to release various cytokines and chemokines in response to inflammatory stimuli (31) . We thus examined the effects of proinflammatory treatments on the pattern of proteins secreted by cultured striatal astrocytes.
Treating cells for 18 h with either LPS (1 µg/ml) or two pro-inflammatory cytokines, IL1-β (200 pg/ml) and TNF-α (10 ng/ml), respectively, increased the amount of four protein species (B2MG, ceruloplasmin, complement C3 α and β chains) in the medium conditioned by striatal astrocytes (Fig. 5A) . In contrast, their intracellular level remained unchanged (data not shown). Surprisingly, the astrocytic secretion of pentraxin related protein-3 (PTX3), a protein known to be highly induced by IL1-β or TNF-α in several cell types (32-34), was not increased by the proinflammatory treatments performed in the present study (data not shown).
Two additional proteins appeared in the supernatant of cells exposed to these treatments (Fig.   5A ). The first one is chitinase-3 like protein-1 (C3L1), a glycoprotein of the chitinase protein family which is thought to contribute to the capacity of cells to respond to changes in their environment (35) and is increased in the serum of patients with inflammatory diseases such as osteoarthritis and rheumatoid arthritis (36). The second one is neutrophil gelatinase-associated lipocalin (NGAL), a protein which was originally identified to be associated with 92-kDa gelatinase/matrix metalloproteinase 9 (MMP9) and secreted in specific granules from activated neutrophils (37). Lipocalins are a family of mainly extracellular proteins involved in the binding, transport and presentation of small lipophilic molecules, including retinoids, steroids and fatty acids (38). NGAL was one of the major proteins identified in the medium conditioned by striatal astrocytes treated with LPS or IL1-β (the NGAL isoformes represent 10.4 ± 2.5 and 6.6 ± 1.7% of the total amount of extracellular proteins in cultures treated with LPS and IL-1β, respectively). We have verified that pro-inflammatory treatments did not significantly decrease cell viability, as assessed by the MTT assay (93 ± 5, 97 ± 2 and 97 ± 3 % of cell survival measured in cultures treated with LPS, IL1-β and TNF-α, respectively, n = 3). Moreover, these treatments did not alter membrane integrity of astrocytes, a process that could be responsible for the increased expression of some proteins in culture supernatant, as indicated by the lack of PI incorporation in cell nuclei (less than 0.1% of PI positive cells in cultures exposed to sham or pro-inflammatory treatments).
Next, we have examined whether astrocytes isolated from other brain regions exhibited differences in reactivity to proinflammatory treatments. We focused on LPS, because this treatment was the most efficient in stimulating the secretion of the aforementioned proteins in Treating astrocytes isolated from the cerebral cortex, the hippocampus and the cerebellum with LPS increased the secretion of B2MG, ceruloplasmin, complement C3 (α and β chains) and NGAL in a same extent as that observed in striatal cultures (Fig. 5B) . LPS also markedly stimulated the secretion of C3L1 in cortical cultures. However, a much lower expression of C3L1 was detected in supernatants of cerebellar astrocytes exposed to LPS (Fig. 5B) . C3L1
was already detectable in the supernatant of untreated astrocytes from the hippocampus and its secretion was strongly stimulated by LPS (Fig. 5B) .
Detection in the cerebrospinal fluid of proteins released by astrocytes
Several proteins identified in the medium conditioned by astrocytes, such as B2MG, complement C3 α and β chains, apolipoprotein E and cystatin C, are known as major protein constituents in the human CSF (39). This suggests that astrocytes may be an important source of proteins in the CSF. To our knowledge, no proteomic map of mouse CSF is available. To determine which proteins released by astrocytes are present in the CSF, a proteomic analysis of mouse CSF proteins was performed. The mouse CSF 2-D gel map was compared with the 2-D gel map of proteins released by astrocytes (Fig. 6 ). As observed in human CSF (40), the mouse CSF showed an enrichment in plasma proteins such as albumin, apolipoprotein A1, transferrin, α 1 -antitrypsin, α 2 -macroglobulin, hemopexin and transthyretin. In addition, more than two thirds of the proteins identified in the astrocyte-conditioned medium were also detectable in the mouse CSF (Fig. 6 ). They include proteins secreted through a BFA-sensitive pathway such as complement chains and ceruloplasmin, and proteins released through a BFAinsensitive mechanism, including PEBP, 14-3-3 proteins, antioxidant proteins (thioredoxin peroxidases 1 and 2, AOP2 and superoxide dismutase) and several cytosolic enzymes.
DISCUSSION
In the present study, using a proteomic approach based on MALDI-TOF mass spectrometry, we identified more than 30 proteins that accumulate in the conditioned medium of cultured astrocytes (see Fig. 7 ). The astrocytic secretion of several of these proteins, including complement C3, apolipoprotein E, ceruloplasmin, transcobalamin II and DBI has already been described (12) (13) (14) (15) . However, we also identified a set of proteins that have never been reported to be secreted by glial cells. Among these are a series of proteins that influence cell interactions with the extracellular matrix (SPARC and protease inhibitors), antioxidant proteins and several cytosolic proteins.
Our procedure based on silver staining allowed the detection of proteins secreted in relatively low amounts (a few ng) by astrocytic cultures. Silver staining also allows full use of the sensitivity of our MALDI-TOF mass spectrometer (femtomol range). However, despite its relatively high sensitivity, our approach only provides insight into a restrictive population of proteins, presumably the major proteins secreted by astrocytes. Indeed, we detected no growth factor nor cytokine, which are known to be produced by astrocytes, even in cultures exposed to pro-inflammatory treatments.
The comparative analysis between proteins released by astrocyte cultures and the CSF proteome indicated that more than two thirds of the proteins identified in the astrocyteconditioned medium were also detected in the CSF. If the profile of protein secreted by astrocytes in vitro is reflective of proteins released by astrocytes in situ, our results suggest that astrocytes constitute one of the major source of CSF proteins. However, we must point out that the cultured astrocytes used in the present study were isolated from mouse embryos, whereas the CSF was from 2-month-old animals. Moreover, other cell types can contribute to the CSF protein content. A previous study has shown that cultured leptomeningeal cells secrete various CSF proteins (41). Many CSF proteins, such as 14-3-3 proteins, can also be released by neurons, in particular following neurotoxic processes. In this regard, the isoform pattern of 14-3-3 proteins in the human CSF has been considered as diagnostic marker of
Creutzfeldt-Jakob disease (42).
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The comparative analysis of proteins secreted by astrocytes isolated from various CNS regions showed a similar profile of protein secretion, even though a regional specificity was observed for the release of a few protein species. These disparities in secretion profiles may reflect regional differences in vivo, although one cannot exclude that they result from the proliferation of a small subset of the isolated cells in our cultures.
Our results indicate that astrocytes can secrete proteins from the biosynthetic pathway by exocytosis of secretory vesicles. This conclusion is supported by 1) the inhibition of the secretion of several proteins by BFA, a specific inhibitor of exocytotic vesicle assembly, and
2) the accumulation of these proteins in the extracellular medium compared with their low amounts in whole cell extracts. We also provide evidence that an alternative pathway With regard to function, antioxidant proteins constitute the largest group of proteins identified in astrocyte-conditioned medium. These proteins may contribute to the well-documented neuroprotective effect of astrocytes against oxidative stress (48). GST class-mu, the unique GST identified in the astrocyte-conditioned medium, shows a high detoxifying activity toward 4-hydroxy-2-nonenal which is the major hydroxyalkenal formed during the peroxidation of polyunsaturated fatty acid and is highly cytotoxic to neuronal cells (49,50). Astrocytes also release 3 peroxiredoxins (peroxiredoxin 1 and 2, AOP2), which belong to a family of enzymes that reduce hydroperoxides and might play a major role in the clearance of low concentrations of H 2 O 2 , such as those measured in the CNS (51). All peroxiredoxins except AOP2 share two conserved reactive cystein residues in the active site and use thioredoxin as a physiological electron donor (28) . A recent study has demonstrated that AOP2, which contains only one of the conserved cystein residues, binds to cyclophilin A and that this protein supports its peroxidase activity as an immediate electron donor (51). This suggests that cyclophilin A released by astrocytes also contributes to extracellular peroxidase activity.
Finally, ceruloplasmin, which is essential for brain iron metabolism, may also participate in the antioxidant function of astrocytes (52).
Proteases and protease inhibitors constitute another major group of proteins secreted by astrocytes that may modulate vulnerability to neurotoxicity. In this regard, both beneficial and detrimental effects on neuronal survival have been attributed to extracellular proteases, including matrix metalloproteinases (MMPs) (53-55). Our study suggests that astrocytes are an important source of MMP inhibitors rather than MMPs. We also provide evidence that astrocytes release substantial amounts of the multifunctional protein PEBP, which was recently identified as a major inhibitor of serine proteases including thrombin, neuropsin and trypsin (26) .
Extracellular proteases also remodel pericellular microenvironment, primarily through the cleavage of extracellular matrix components. They participate in structural changes in neuronal architecture and in the pattern and number of neuronal connections associated with long-lasting forms of synaptic plasticity (56, 57) . SPARC is another major protein constitutively released by astrocytes that may contribute to synaptic plasticity (58) . Finally, the astrocytic secretion of the octadecaneuropeptide DBI, a negative allosteric modulator of GABA A receptor channels, may participate in the regulation of GABAergic synaptic transmission (25, 59 ).
In conclusion, the present study provides the first unbiased characterization of the major proteins secreted by astrocytes in vitro. If astrocytes in situ produce the same protein species, the secretion of proteins may be one critical mechanism by which astrocytes modulate neuronal survival and function. Immunoblotting was performed with a polyclonal anti-CYSC antibody and a polyclonal anti-B2MG antibody (1/5,000 dilution each). Table 1 . Table 1 : Proteins identified in the conditioned medium of cultured astrocytes from various brain regions. The proteins listed are 1) proteins whose release by astrocytes is inhibited by BFA and 2) proteins which are more than 2.5 fold enriched in the medium conditioned by astrocytes versus whole cell extract. The scores of two additional proteins (HSP90 and β-actin) which are illustrated in Figure 3 are also indicated. When several spots are identified as a single protein, the sequence coverage resulting from the analysis of the major spot is indicated. * The SWISS-PROT and TrEMBL accession numbers are listed.
